B16F10 Cell Membrane-Based Nanovesicles for Melanoma Therapy Are Superior to Hyaluronic Acid-Modified Nanocarriers.
Li Y, Ruan S, Guo J, He Z, Xia Q, Wu T, Wang Z, Li Z, Hu H, Jing Q, Hou X, He Y, Zhang B, Feng N, Zhang Y.
Li Y, et al. Among authors: wu t.
Mol Pharm. 2022 Aug 1;19(8):2840-2853. doi: 10.1021/acs.molpharmaceut.2c00212. Epub 2022 Jul 18.
Mol Pharm. 2022.
PMID: 35850109